Schnitzler syndrome is a rare acquired autoinflammatory disease characterized by monoclonal immunoglobulin M gammopathy and urticaria. Clinical features include fever, urticarial rash, myalgia, arthralgia, hepatosplenomegaly, and enlarged lymph nodes. Schnitzler syndrome is often underdiagnosed and not usually suspected until more common autoimmune, neoplastic, and infectious etiologies are excluded. Anakinra, an interleukin-1 receptor antagonist, is the first-line treatment and has been shown to provide fast and sustained symptom relief [1][2][3].
IMAGES IN HEMATOLOGY
AJH AJHA 50-year-old man with presumed Castleman disease/POEMS syndrome (a multisystem syndrome combining polyneuropathy, organomegaly, endocrinopathy, M component, and skin changes) presented for evaluation of persistent hip pain and a "burning" rash of 3 years' duration. He had previously been treated with systemic corticosteroids, lenalidomide, rituximab, and bortezomib, and with an autologous stem cell transplant, resulting in initial improvement but eventual recurrence of symptoms. His physical examination revealed small, slightly edematous, pink plaques involving the back (Image 1A), trunk, and arms (Image 1B). Laboratory tests revealed elevated inflammatory markers, with an erythrocyte sedimentation rate of 75 mm/hr (reference range, 0-22 mm/hr) and C-reactive protein of 65 mg/L (reference range, 0-8 mg/L), and small monoclonal immunoglobulin M j protein. Magnetic resonance imaging demonstrated patchy intramedullary osteosclerosis of the left iliac wing, with bone marrow edema in the left acetabulum and both knees. Whole-body fludeoxyglucose (FDG) positron emission tomography/computed tomography revealed mild increased 18